Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC
Clinical trial NCT07741448 · RECRUITING
Trial details
- NCT number
- NCT07741448
- Sponsor
- Zhiquan Hu
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-15
- Primary completion
- 2028-08-15
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.